Browse Studies — Arctuva | Arctuva

Browse Studies About FAQ

Sign in Get started

Browse studies

Find your next paid study

1 recruiting study matching your filters

Newest first Highest paying

Filters

Condition

Location

Phase

Min compensation ($)

Max compensation ($)

A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients With Mucopolysaccharidosis Type I Hurler-Scheie and Scheie

A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.

Mucopolysaccharidosis IH/SMucopolysaccharidosis IS

Immusoft of CA, Inc.NCT05682144

Arctuva

Connecting verified participants with clinical studies that matter.

Platform

Browse Studies
Join Arctuva
My Profile

Company

About
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Arctuva. All rights reserved.